Antimicrobial resistance of Vibrio cholerae O1 serotype Ogawa isolated in Manhiça District Hospital, southern Mozambique

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 3, 2007, Pages 662-664

  Mandomando, Inácio ^a,b   Espasa, Mateu ^a   Vallès, Xavier ^a   Sacarlal, Jahit ^a,c   Sigaúque, Betuel ^a,b   Ruiz, Joaquim ^d   Alonso, Pedro ^a,d  

^a Ministérioda Saúde   (Mozambique)

^b INSTITUTO NACIONAL DE SAÚDE   (Mozambique)

^c EDUARDO MONDLANE UNIVERSITY   (Mozambique)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cholera; Diarrhoea; Susceptibility profile

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CHLORAMPHENICOL; COTRIMOXAZOLE; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE;

AFRICA; AGGLUTINATION TEST; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHEMICAL REACTION; CHOLERA; CONTROLLED STUDY; DIFFUSION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; RECTUM; SEROTYPE; VIBRIO CHOLERAE;

ANTI-BACTERIAL AGENTS; CHOLERA; DATA INTERPRETATION, STATISTICAL; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOZAMBIQUE; RECTUM; RURAL POPULATION; VIBRIO CHOLERAE O1;

EID: 34548138989     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm257     Document Type: Article

References (13)

1. WHO. Cholera in 1997. Weekly Epidemiol Record 1998; 73: 201-8.
2. Rao S, Pai M, Iyanar A et al. Sanitation for rural communities: first win the people's support. Word Health Forum 1997; 18: 262-5.
3. WHO. Report on cholera control programme in Mozambique. WHO Global Task Force on Cholera Control Geneva: WHO, 2003.
4. Acosta CJ, Galindo CM, Kimario J et al. Cholera outbreak in southern Tanzania: Risk factors and patterns of transmission. Emerg Infect Dis 2001; 7: 583-7.
5. Folgosa E, Mastrandrea S, Cappuccinelli P et al. Molecular identification of pathogenicity genes and ERIC types in Vibrio cholerae O1 epidemic strains from Mozambique. Epidemiol Infect 2001; 127: 17-25.
6. Dalsgaard A, Forslund A, Sandvang D et al. Vibrio cholerae O1 outbreak isolates in Mozambique and South Africa in 1998 are multiple-drug resistant, contain the SXT element and the aadA2 gene located on class 1 integrons. J Antimicrob Chemother 2001; 48 827-38.
7. Okeke IN. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 2005; 5: 481-93.
8. Garg P, Sinha S, Chakraborty R et al. Emergence of fluoroquinolone-resistant strains of Vibrio cholerae O1 biotype El Tor among hospitalized patient with cholera in Calcutta, India. Antimicrob Agents Chemother 2001; 45: 1605-6.
9. Nhacolo AO, Nhalungo DA, Sacoor CN et al. Levels and trends of demographic indices in southern rural Mozambique: Evidence from demographic surveillance in Manhica district. BMC Public Health 2006; 6: 291.
10. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptility Tests. Approved Standard M2-A9. CLSI, Wayne, PA, USA, 2006.
11. Chintu C, Bhat GJ, Walker AS et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): A double-blind randomised placebo-controlled trial. Lancet 2004; 364: 1865-71.
12. Mandomando I, Macete E, Ruiz J et al. Etiology of diarrhea in children younger than 5 years of age admitted in a rural hospital of Southern Mozambique. Am J Trop Med Hyg 2007; 76: 522-7.
13. Sarkar K, Ghosh S, Niyogi SK et al. Shigella dysenteriae type 1 with reduced susceptibility to fluorequinolones. Lancet 2003; 361: 785.